RESUMO
Objective: To assess the association between dynamic patterns of change in body mass or fat mass and stroke. Methods: A population-based cohort of participants was selected from the China Health and Retirement Longitudinal Study (CHARLS). Body mass and fat mass were measured using obesity-related indices, including weight, body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), lipid accumulation product (LAP), and visceral adiposity index (VAI). Five changed patterns were defined: low-stable, decreasing, moderate, increasing, and persistent-high. Logistic regression analysis was performed to evaluate the association between obesity-related indices and stroke. Results: A total of 5,834 participants were included, and the median age was 58.0 years. During a 7-years follow-up period, 354 (6.1%) participants developed stroke. The baseline levels of obesity-related indices were significantly associated with incident stroke. Regarding the dynamic change patterns, the low-stable pattern carried the lowest odds for stroke and the persistent-high pattern had the highest odds for stroke, with odds ratios of all the indices ranging from 1.73 to 3.37 (all P < 0.05). The increasing pattern was also associated with a higher odds of stroke, whereas the moderate pattern of weight, BMI, and WHtR was comparable to the low-stable pattern in terms of stroke. Conclusion: Current status and dynamic changes in body mass and fat mass were significantly associated with incident stroke. Maintaining the low-stable pattern of body mass and fat mass as measured by weight, WC, BMI, WHtR, LAP, and VAI may be an alternative strategy for primary stroke prevention.
RESUMO
PURPOSE: Chronic low-grade inflammation is detected in obese and diabetic individuals. Tetracyclines, used as antibiotics for years, have been demonstrated to have diverse non-bactericidal effects, including anti-tumor and anti-inflammatory activities. This study aimed to investigate whether doxycycline at sub-antimicrobial concentrations could improve glycemic control in mice fed a high-fat diet, through its anti-inflammatory activities. METHODS: C57BL/6J mice were fed with a high-fat diet to induce diabetic and obese conditions. Three sub-antimicrobial dosages of doxycycline (200, 20, and 2 µg/mL) were added to drinking water for 23 weeks during the housing phase. RESULTS: Doxycycline at 200 µg/mL tended to increase body weight, islet mass, and the percentage of large islets (diameter >350 µm). At 20 µg/mL, doxycycline significantly improved glucose tolerance and decreased fasting blood glucose. At 2 µg/mL, doxycycline increased the percentage of small islets (diameter <80 µm). Serum C-reactive protein and lipopolysaccharide levels significantly decreased while the beta-cell ratio increased in all doxycycline-administered mice. CONCLUSION: Our results suggest that doxycycline, even at an extremely low dose, could improve glycemic control and islet morphology via its anti-inflammatory activities.